Polymeric tryptamine-based alkaloids belong to a structurally and biologically fascinating class of natural products.[1] Whereas the vast majority of such molecules are linked through C–C bonds, a small subset are linked from the C3 of one indole nucleus to the N1 of another. Psychotetramine (1, Figure 1A) represents the curious case of a tryptamine tetramer containing both types of connectivity: a C3–C3 linked dimer bonded to a C3–N1 dimer through an unusual C7–N1 linkage. This interesting alkaloid was isolated in 2004,[2] but due to the limited quantity from Nature and its complicated NMR spectra, a final chemical structure including stereochemistry was not determined. In this communication, a joint venture between our groups (H. T. and P. S. B.) is described, leading to the total synthesis and final structure elucidation of 1. The pursuit of this complex natural product also led to an efficient enantioselective synthesis of the related alkaloid (+)-psychotrimine, an improved procedure for direct-indole aniline coupling, and one of the most complex and demanding contexts for a Buchwald-Hartwig amination.
Figure 1.
Modular retrosynthetic analysis for rapid structure elucidation.
Psychotetramine (1) was isolated from a rubiaceous plant, Psychotria rostrata, and exhibited (c 0.2, CHCl3). The molecular formula (C44H50N8), obtained by high-resolution FABMS analysis as well as the 13C NMR spectrum (see SI), revealed 26 aromatic carbons and 18 sp3 carbons, including three aminoacetal carbons, indicated that 1 composed of four tryptamine-related moieties containing one indole and three indoline chromophores. Detailed analyses of MS fragment pattern (see SI) and 2D-NMR data indicated the presence of a chimonanthine unit, joined together by a N1–C7 and a C3–N1 linkage respectively. This type of linkage at the chimonanthine aniline nitrogen is the first reported of hitherto known polymeric tryptamine-related alkaloids.[1] A final chemical structure including relative and absolute stereochemistry could not be determined by spectroscopic means.
Psychotetramine (1) is a challenging target, especially without configurational assignment of its six stereogenic centers and the practical demands of molecules with high nitrogen content. Since the three pyrrolidine subunits of 1 must be cis-fused, there are eight possible stereoisomers (four pairs of enantiomers). The stereochemical determination and constitutional assignment of 1 was systematically accomplished through four “rounds” of total synthesis as graphically summarized in Figure 1B.
In order to systematically elucidate the structure of 1, a modular retrosynthetic plan was devised (Figure 1A). The C7–N1 linkage was ruptured leading to two fragments of equal size and complexity (2 and 3). The union of fragments 2 and 3 was anticipated to test the limits of the Buchwald-Hartwig amination.[3] Fragment 2, a chimonanthine derivative, could be fashioned rapidly as a mixture of isomers using Takayama’s procedure for dimerization[4]or controllably in Movassaghi’s elegant stepwise procedure.[1q] Fragment 3, an intermediate in the total synthesis of psychotrimine,[5] could be made in both racemic and enantiopure fashion by using the direct indole-aniline coupling of o-iodoaniline to 5, followed by Larock annulation on adduct 4.
In round 1, two diastereomers (6 and 7) were synthesized using a meso-chimonanthine fragment (in blue) and a racemic truncated psychotrimine fragment 3 (in green and black). However, neither of these structures matched the spectral data of psychotetramine (1). In round 2, the racemic d/l-chimonanthine series was coupled to the racemic truncated psychotrimine portion 3 to deliver diastereomers (9 and 10), one of which matched the spectral data of psychotetramine. Up until this point, the Takayama procedure for dimerization was employed since his rapid procedure allowed us to draw some conclusions quickly. In round 3, reasoning that the chimonanthine portion would correspond to the naturally occurring l-series, diastereomers 11 and 1 were synthesized by using Movassaghi’s procedure to procure fragment 12. Gratifyingly, one of those diastereomers matched psychotetramine (1), and thus, the final round involved the truncated psychotrimine fragments being synthesized in an enantiopure fashion leading to the finding that the structure of psychotetramine corresponds to 1 (see box, Figure 1B). Notably, the top portion of 1 has the same absolute configuration as that of psychotrimine (23) as determined by Takayama in their enantiospecific synthesis.[5c] Albeit speculative, this may suggest similar biosynthetic pathways of the two natural products.
The total synthesis of (+)-1 is illustrated in Scheme 1 and is representative of the syntheses of those preceding it (Rounds 1–3, Figure 1B). Beginning with 7-bromo-d-tryptophan derivative ((−)-13, see SI for preparation), direct indole-aniline coupling with o-iodoaniline would furnish the required adduct (+)-14. However, previously reported conditions[5a,d]on (−)-13 (see Table 1, Entries 1–5) failed to give adduct (+)-14 in reasonable yield. Drawing inspiration from our mechanistic studies and previous reports on electrophilic vicinal difunctionalizations of tryptamines,[6]it was found that Brønsted acids effectively promoted the reaction, affording (+)-14, even at temperatures as low as −35 °C with greater than 20:1 dr (Entries 6–11). This contrasted with previously reported conditions[5a,d] wherein reasonable conversions did not proceed until above 0 °C (Entries 4–5). The best result was obtained with the use of PPTS as an additive, delivering (+)-14 in 66% yield (Entry 6). Interestingly, these newly developed conditions also improved the yield on the non-brominated analog 25 (Entries 12–13), brominated and non-brominated Boc-Trp-OMe products 26 and 27 (Entries 14–18), as well as the previously reported brominated tryptamine derivative product 28 (Entries 19–21). The versatility of this new indole-aniline coupling procedure is further exemplified by the successful transformation of tryptophol to give compound 29 in 56% yield.
Scheme 1.
Total synthesis of (+)-psychotetramine (1) and (+)-psychotrimine (23). Reagents and Conditions: a) PPTS (1.0 equiv), o-iodoaniline (1.2 equiv), NIS (1.6 equiv), MeCN, −45 °C to −35 °C, 66%; b) Pd(OAc)2 (0.21 equiv), LiCl (0.9 equiv), 15 (2.7 equiv), Na2CO3 (2.6 equiv), DMF, 102 °C, 1 h, 46%; c) 5 N aq. KOH, THF/MeOH (1:2), 23 °C,1 h; d) THF/MeCN (2:1), i-BuOCOCl (1.2 equiv), NMM (1.0 equiv), 0 °C then 23 °C, 15 min, then 0 °C, 18 (1.2 equiv), Et3N (1.0 equiv), 15 min, then t-BuSH (10 equiv), hυ, 10 min, 23 °C, 72% from 16; e) CuI (0.32 equiv), K2CO3 (7.0 equiv), 20 (0.60 equiv), 21 (3.0 equiv), 1,4-dioxane, 101 °C, 9 h, 89%; f) Red-Al (16 equiv), toluene, 110 °C, 5 min, 89%; g) Pd2(dba)3 (5 mol % based on 19), RuPhos (20 mol % based on 19), NaOt-Bu (2.7 equiv), 12 (0.38 equiv), PhMe, 100 °C, 5 h, 41% from 12; h) AlH3 (26 equiv), THF, 60 °C, 5 min, 68%. MeCN = acetonitrile, DMF = N,N-dimethylformamide, THF = tetrahydrofuran, NMM = N-methylmorpholine.
Table 1.
Optimization Table for Indole-Aniline Coupling.
![]() | |||
|---|---|---|---|
| Product | # | Conditions | %[a] |
|
14 X=Br Y=NCO2Me Z=CO2Me Entries 1–11 |
1 | NIS (1.5 eq), −45 to −35 °C | 0 |
| 2 | NIS (1.1 eq), EtNO2, −78 °C | 0 | |
| 3 | Koser’s reagent (3.0 eq), 0 °C | 0 | |
| 4 | NIS (3.5 eq), Et3N (1.2 eq), 0 to 23 °C | 32[b] | |
| 5 | NIS (1.5 eq), MeOH:MeCN (1:20), −45 to 3 °C | 33[b] | |
| 6 | NIS (1.6 eq), PPTS (1.0 eq), −45 to −35 °C | 66 | |
| 7 | NIS (1.6 eq), (±)-CSA (1.0 eq), −45 to −35 °C | 46 | |
| 8 | NIS (1.6 eq), TsOH (1.0 eq), −45 to −35 °C | 30 | |
| 9 | NIS (1.6 eq), TFA (1.0 eq), −45 to −35 °C | 23 | |
| 10 | NIS (1.6 eq), Sc(OTf)3 (1.0 eq), −45 to −35 °C | 58 | |
| 11 | NIS (1.6 eq), AcOH (1.0 eq), −45 to −35 °C | 23 | |
| 25, X=H | 12 | NIS (1.5 eq), MeOH:MeCN (1:20), −45 °C | 68 |
| Y=NCO2Me Z=CO2Me |
13 | NIS (1.6 eq), PPTS (1.0 eq), −45 to −35 °C | 75 |
| 26, X=Br | 14 | NIS (3.5 eq), Et3N (1.2 eq), 0 to 23 °C | 24[b] |
| Y=NBoc | 15 | NIS (1.5 eq), MeOH:MeCN (1:20), −45 °C | 22[c] |
| Z=CO2Me | 16 | NIS (1.6 eq), PPTS (1.0 eq), −45 to −35 °C | 64 |
| 27, X=H | 17 | NIS (1.5 eq), MeOH:MeCN (1:20), −45 °C | 79[d] |
| Y=NBoc Z=CO2Me |
18 | NIS (1.6 eq), PPTS (1.0 eq), −45 to −35 °C | 94 |
| 28 | 19 | NIS (3.5 eq), Et3N (1.2 eq), −45 to −35 °C | 24 |
| X=Br Y=NCO2Me |
20 | NIS (3.5 eq), Et3N (1.2 eq), −45 to 23 °C | 61–67[d] |
| Z=H | 21 | NIS (1.6 eq), PPTS (1.0 eq), −45 to −35 °C | 70 |
|
29, X=H Y=O, Z=H |
22 | NIS (1.6 eq), PPTS (1.0 eq), −45 to −35 °C | 56 |
Isolated yield.
No conversion was observed until warmed above 0 °C.
A dr of 1.2:1 was observed.
Best yields previously reported.
All reactions were run on at least 20 mg scale and in MeCN as solvent, unless otherwise stated. A dr of >20:1 was observed unless otherwise stated. Either enantiomer of 13 was used in the optimization study to obtain 14.
NIS = N-iodosuccinimide, PPTS = pyridinium p-toluenesulfonate, CSA = camphorsulfonic acid.
Subsequent Larock annulation[7] of (+)-14 led to tryptamine-tryptophan dimer (+)-16 in 46% yield. Following saponification with aqueous KOH and Barton decarboxylation,[8] enantiopure (+)-19 was in hand without any sign of debromination under the optimized conditions in 72% yield over two steps. The key subunit coupling of the truncated psychotrimine portion (+)-19 with chimonanthine derivative (+)-12[1q] was accomplished via an unusually complex Buchwald-Hartwig amination[3]. It is noteworthy that amination between two sterically congested coupling partners, in this case between an indoline nitrogen (of chimonanthine (+)-12) and an ortho substituted aryl halide (+)-19, in the presence of a total of four N–Hs, is a challenging task that required significant optimization; a selected listing of parameters that were screened is shown in Table 2.
Table 2.
Optimization Table for Buchwald-Hartwig amination of 19.
![]() | ||||
|---|---|---|---|---|
| Entry | Ligand | Base (eq) | 12 : 19 (eq) | Yield[a] |
| 1[b] | RuPhos | NaOtBu (2.5) | 1.5 : 1 | 30 |
| 2 | SPhos | NaOtBu (2.5) | 1.5 : 1 | <30 |
| 3 | XPhos | NaOtBu (2.5) | 1.5 : 1 | <20 |
| 4[c] | RuPhos | LHMDS (3.0) | 1.5 : 1 | Trace |
| 5 | RuPhos | K2CO3 (5.0) | 1.5 : 1 | <15 |
| 6[d] | P(tBu)3•HBF4 | NaOtBu (2.5) | 1.5 : 1 | Trace |
| 7[e] | RuPhos | NaOtBu (2.5) | 1.5 : 1 | 10–16 |
| 8[e] | RuPhos | NaOtBu (4.0) | 3.0 : 1 | 10 |
| 9[e] | RuPhos | NaOtBu (4.0)[f] | 1 : 3.0 | 32[g] |
| 10[e] | RuPhos | NaOtBu (3.0)[f] | 1 : 2.0 | 17[g] |
| 11[e] | RuPhos | NaOtBu (2.7)[f] | 1 : 2.6 | 41[g] |
Isolated yield.
Slow addition of Pd2(dba)3 has no effect on yield.
Reaction was performed at 65 °C in THF.[10a]
Pd(OAc)2 (5 mol %) was used with ligand (6 mol %).
Reaction was performed on at least 10 mg scale of 19.
Base equiv based on 12.
Yield based on 12.
All reactions were run with 5 mg of 19 unless otherwise stated. Reactions were monitored with LC-MS for a maximum of 12 h. Other solvents (tBuOH, 1,4-dioxane), temperature and amount of base (molar sum of 12 + 19) were screened.
Thus, it was found that RuPhos[3c] provided the best results as compared to that of other Buchwald ligands known to form C–N bonds such as XPhos and SPhos.[9] Buchwald’s recent modified procedure[10a] using LHMDS and the use of weaker bases[3f] such as Cs2CO3 and K2CO3 in t-BuOH or toluene as solvent all proved to be less effective. The water-mediated catalyst preactivation protocol[10b] was also unsuccessful. Initially, it was hypothesized that the yield of the reaction was hampered by rapid debromination of the truncated psychotrimine fragment (+)-19. Means to reduce debromination, such as the slow addition of the Pd2(dba)3, were unsuccessful. Using a large excess of the chimonanthine-derived fragment (+)-12 also failed to improve the yield of the reaction. Gratifyingly, the yield of the reaction improved to 41% using an excess (2.6 equiv., 47% of which is recoverable) of (+)-19 rather than the chimonanthine fragment (+)-12.
The total synthesis was completed using alane[11] to reductively convert the methylcarbamate groups to the methyl groups expressed in the natural product (+)-1. With a scalable route to enantiopure (+)-19 in hand, an enantioselective total synthesis of psychotrimine (23) was also pursued. Thus, copper-mediated amination of (+)-19 with the known tryptamine derivative 21, followed by reduction of the methylcarbamate groups using Red-Al furnished psychotrimine (+)-23 rapidly, (c 1.0, CHCl3) (natural (c 0.2, CHCl3).[5c] This represents the shortest and highest yielding route to enantiopure psychotrimine (23) (9 steps, 7% overall from 7-bromoindole).
Synthetic psychotetramine (1) was spectroscopically similar to the spectra recorded in 2004 for nat-1 but it was not identical. Although the 1H NMR is a nearly exact match to that reported by Takayama, the 13C NMR had several small differences (mainly in the N-Me region). It was found that the 1H NMR displayed small differences as a function of concentration and solvent batch. The structure was finally secured upon repurification of the last remaining sample of nat-1 followed by both co-HPLC and NMR with a synthetic sample.
In conclusion we have reported a solution to the stereochemical puzzle posed by psychotetramine (1) and the shortest and most efficient route thus far to access enantiopure psychotrimine (23). Along the way, a new general protocol was invented for the direct aniline-indole coupling that utilizes PPTS as a crucial additive. Overall, the described total synthesis showcases the utility of a modular approach to the synthesis of chimonanthine-psychotrimine hybrids through three powerfully simplifying assembly events: homodimerization of tryptophan[1q,4], heterocoupling of tryptophan with o-iodoaniline,[5a,d] and Buchwald-Hartwig amination.[3]
Footnotes
Prof. Stephen L. Buchwald is gratefully acknowledged for advice and generous samples of ligands. Funding for this work was provided by Bristol-Myers Squibb, the NIH/NCI (CA134785) and A*STAR for a predoctoral fellowship to K. Foo.
Supporting information for this article is available on the WWW under http://www.angewandte.org or from the author.
Contributor Information
Klement Foo, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037 (USA), Fax: (+1) 858-784-7375.
Timothy Newhouse, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037 (USA), Fax: (+1) 858-784-7375.
Ikue Mori, Graduate School of Pharmaceutical Sciences, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522 (Japan).
Hiromitsu Takayama, Graduate School of Pharmaceutical Sciences, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522 (Japan).
Phil S. Baran, Email: pbaran@scripps.edu, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037 (USA), Fax: (+1) 858-784-7375.
References
- 1.Vinblastine: Ishikawa H, Colby DA, Seto S, Va P, Tam A, Kakei H, Rayl TJ, Hwang I, Boger DL. J. Am. Chem. Soc. 2009;131:4904. doi: 10.1021/ja809842b. Yokoshima S, Ueda T, Kobayashi S, Sato A, Kuboyama T, Tokuyama H, Fukuyama T. J. Am. Chem. Soc. 2002;124:2137. doi: 10.1021/ja0177049. Mangeney P, Andriamialisoa RZ, Langlois N, Langlois Y, Potier P. J. Am. Chem. Soc. 1979;101:2243. doi: 10.1021/jo01336a006. Kutney JP, Choi LSL, Nakano J, Tsukamoto H, McHugh M, Boulet CA. Heterocycles. 1988;27:1845. Kuehne ME, Matson PA, Bornmann WG. J. Org. Chem. 1991;56:513. Magnus P, Mendoza JS, Stamford A, Ladlow M, Willis P. J. Am. Chem. Soc. 1992;114:10232. Asperazine: Govek SP, Overman LE. J. Am. Chem. Soc. 2001;123:9468. doi: 10.1016/j.tet.2007.05.127. Govek SP, Overman LE. Tetrahedron. 2007;63:8499. Quadrigemine C: Lebsack AD, Link TJ, Overman LE, Stearns BA. J. Am. Chem. Soc. 2002;124:9008. doi: 10.1021/ja0267425. Himastatin: Kamenecka TM, Danishefsky SJ. Angew. Chem., Int. Ed. 1998;37:2993. doi: 10.1002/(SICI)1521-3773(19981116)37:21<2993::AID-ANIE2993>3.0.CO;2-I. Kamenecka TM, Danishefsky SJ. Angew. Chem., Int. Ed. 1998;37:2995. doi: 10.1002/(SICI)1521-3773(19981116)37:21<2995::AID-ANIE2995>3.0.CO;2-6. Kamenecka TM, Danishefsky SJ. Chem.–Eur. J. 2001;7:41. doi: 10.1002/1521-3765(20010105)7:1<41::aid-chem41>3.0.co;2-d. Perophoramidine: Fuchs JR, Funk RL. J. Am. Chem. Soc. 2004;126:5068. doi: 10.1021/ja049569g. Chimonanthine: Hendrickson JB, Göschke R, Rees R. Tetrahedron. 1964;20:565. Scott AI, McCapra F, Hall ES. J. Am. Chem. Soc. 1964;86:302. doi: 10.1021/ja01017a041. Link JT, Overman LE. J. Am. Chem. Soc. 1996;118:8166. Movassaghi M, Schmidt MA. Angew. Chem., Int. Ed. 2007;46:3725. doi: 10.1002/anie.200700705. Haplophytine: Ueda H, Satoh H, Matsumoto K, Sugimoto K, Fukuyama T, Tokuyama H. Angew. Chem., Int. Ed. 2009;48:7600. doi: 10.1002/anie.200902192. Nicolaou KC, Dalby SM, Li S, Suzuki T, Chen DYK. Angew. Chem., Int. Ed. 2009;41:7480. doi: 10.1002/anie.200904588. Communesin F: Yang J, Wu H, Shen L, Qin Y. J. Am. Chem. Soc. 2007;129:13794. doi: 10.1021/ja075705g.
- 2.The absolute configuration of psychotetramine is not known, see: Mori I. M.S. Thesis. Japan: Chiba University; 2004.
- 3.a) Hartwig JF. Acc. Chem. Res. 2008;41:1534. doi: 10.1021/ar800098p. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Charles MD, Schultz P, Buchwald SL. Org. Lett. 2005;7:3965. doi: 10.1021/ol0514754. [DOI] [PubMed] [Google Scholar]; c) Milne JE, Buchwald SL. J. Am. Chem. Soc. 2004;126:13028. doi: 10.1021/ja0474493. [DOI] [PubMed] [Google Scholar]; d) Wolfe JP, Wagaw S, Marcoux J-F, Buchwald SL. Acc. Chem. Res. 1998;31:805. [Google Scholar]; d) Hartwig JF. Acc. Chem. Res. 1998;31:852. [Google Scholar]; f) Wolfe JP, Buchwald SL. Tetrahedron Lett. 1997;38:6359. [Google Scholar]
- 4.Ishikawa H, Takayama H, Aimi N. Tetrahedron Lett. 2002;43:5637. [Google Scholar]
- 5.a) Newhouse T, Baran PS. J. Am. Chem. Soc. 2008;130:10886. doi: 10.1021/ja8042307. [DOI] [PubMed] [Google Scholar]; b) Matsuda Y, Kitajima M, Takayama H. Org. Lett. 2008;10:125. doi: 10.1021/ol702637r. [DOI] [PubMed] [Google Scholar]; c) Takahashi N, Ito T, Matsuda Y, Kogure N, Kitajima M, Takayama H. Chem. Comm. 2010;46:2501. doi: 10.1039/b923918a. [DOI] [PubMed] [Google Scholar]; d) Newhouse T, Lewis CA, Eastman KJ, Baran PS. J. Am. Chem. Soc. 2010;132:7119. doi: 10.1021/ja1009458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.a) López CS, Pérez-Balado C, Rodríguez-Graña P, de Lera AR. Org. Lett. 2008;10:77. doi: 10.1021/ol702732j. [DOI] [PubMed] [Google Scholar]; b) Depew KM, Marsden SP, Zatorska D, Zatorski A, Bornmann WG, Danishefsky SJ. J. Am. Chem. Soc. 1999;121:11953. [Google Scholar]
- 7.Larock RC, Yum EK. J. Am. Chem. Soc. 1991;113:6689. [Google Scholar]
- 8.a) Barton DHR, Serebryakov EP. Proc. Chem. Soc. 1962:309. [Google Scholar]; b) Martin SF, Clark CW, Corbett JW. J. Org. Chem. 1995;60:3236. [Google Scholar]
- 9.Maiti D, Fors BP, Henderson JL, Nakamura Y, Buchwald SL. Chem. Sci. doi: 10.1039/C0SC00330A. Advance Article. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.a) Henderson JL, Buchwald SL. Org. Lett. 2010;12:4442. doi: 10.1021/ol101929v. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Fors BP, Krattiger P, Strieter E, Buchwald SL. Org. Lett. 2008;10:3050. doi: 10.1021/ol801285g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Alane was found to be far superior to Red-Al in terms of ease of purification, conversion, and yield.




